Cita 100 mg (Sitagliptin Phosphate Hydrate)

Adult dose

This medication is administered as 100 mg once daily, either as monotherapy or in combination therapy, with a maximum daily dose of 100 mg. This medication can be taken regardless of meals. Patients with renal impairment may require dose adjustments based on kidney function. - Mild renal impairment (eGFR 60-90): No dose adjustment needed - Moderate renal impairment (eGFR 45-60): No dose adjustment needed - Moderate renal impairment (eGFR 30-45):

This medication is used to treat diabetes and helps to control blood sugar levels. However, serious allergic reactions may occur while taking this medication; if symptoms such as skin rash, difficulty breathing, or swelling of the face or neck occur, discontinue use immediately and consult a medical professional. Severe side effects like pancreatitis have been reported. If symptoms such as abdominal pain, nausea, or vomiting occur, stop taking this medication immediately and visit a hospital. This medication should not be used in patients with type 1 diabetes or those with diabetic ketoacidosis, and should be avoided by individuals with hypersensitivity to this medication or its components. Patients with impaired kidney function may require dose adjustments due to increased drug concentration, so if there is a kidney condition, consult a doctor. Additionally, this medication contains a dye called Yellow 5, so individuals allergic to this component should take caution. During treatment, hypoglycemic symptoms may occur, so it is particularly important to monitor blood sugar changes when used with other hypoglycemic agents or insulin. Severe joint pain or skin blistering symptoms may appear, and if these occur, notify a physician immediately. Use of this medication is not recommended for pregnant or nursing women, and safety in children and adolescents under 18 years of age has not been established. Elderly patients may have decreased kidney function, so it is important to have periodic kidney function tests before and during use of this medication. In case of overdose, standard emergency treatment should be administered, and blood dialysis may be required to remove the drug. It is safe to adhere to the precautions mentioned above while taking this medication, and it is advised to consult medical personnel immediately if unusual symptoms occur.

Serious side effects

Urticaria, angioedema, anaphylaxis, exfoliative skin diseases (including Stevens-Johnson syndrome), severe joint pain with disability, blistering dermatitis, acute pancreatitis (including hemorrhagic or necrotizing), acute renal failure, pneumonia, cardiac arrest, elevated liver enzymes, thrombocytopenia, rhabdomyolysis

Mild side effects

• Nasopharyngitis
• upper respiratory infection
• headache
• diarrhea
• indigestion
• nausea
• constipation
• muscle pain
• limb pain
• back pain

This medication should be stored in a tightly sealed container to prevent air exposure. The storage temperature should be kept between 1 and 30 degrees Celsius at room temperature.

Appearance

Orange, round, convex, film-coated tablets on both sides

Package unit

30 tablets/box [10 tablets/PTPX3]